Back to Journals » Therapeutics and Clinical Risk Management » Volume 13

Original Research

Real-world use of PCSK-9 inhibitors by early adopters: cardiovascular risk factors, statin co-treatment, and short-term adherence in routine clinical practice

       
Total article views   HTML views PDF downloads Totals
11,666 Dovepress* 9,891+ 1,561 11,452
PubMed Central* 1,775 488 2,263
Totals 11,666 2,049 13,715
*Since 3 August 2017

View citations on PubMed Central and Google Scholar